GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Q2 FY27 Consolidated Net Profit INR 483.06 million

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 31 Oct 2026, 01:15 PM IST  ·  BSE ID: 8bb60087-c2c5-4ce7-913a-9df275d7a6a8
View Original BSE Filing (PDF)
💡
In Simple Terms
The company released its quarterly earnings, showing a net profit of INR 483.06 million, and reviewed requests to reclassify some owners.
🤖 AI Summary
  • Board approved unaudited consolidated financial results for the quarter and half year ended September 30, 2026.
  • Consolidated Net Profit after Tax was INR 483.06 million for the quarter ended September 30, 2026.
  • Consolidated Total Income for Q2 FY27 reported as INR 2,290.09 million.
  • Board analyzed promoter reclassification requests from promoter group to public category shareholders under Regulation 31A.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Consolidated Total Income (Q2 FY27)
INR 2,290.09 million
7.97
Consolidated Net Profit After Tax (Q2 FY27)
INR 483.06 million
11.50
Consolidated Total Income (H1 FY27)
INR 4,026.82 million
7.45
Consolidated Net Profit After Tax (H1 FY27)
INR 853.99 million
2.57
🏢 How This Affects the Company
💰
Financial Impact
Consolidated Net Profit after Tax increased to INR 483.06 million for Q2 FY27 from INR 433.26 million in Q2 FY26. Consolidated Total Income for Q2 FY27 increased to INR 2,290.09 million from INR 2,120.99 million in Q2 FY26.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
Shareholders are affected by the company's financial performance, as consolidated net profit after tax increased for the quarter. The reclassification requests, if approved, would affect the composition of the promoter group.
🔍
Management Signal
Management approved the financial results and initiated review of promoter reclassification requests, indicating adherence to regulatory requirements and ongoing corporate governance. The Board assessed the requests under Regulation 31A of SEBI (LODR) Regulations, 2015.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Outcome of promoter reclassification requests under Regulation 31A.
Q3 FY27 financial results — observe revenue and profit trends.
Any further corporate announcements regarding strategic initiatives.
LOW RISK The filing primarily reports financial results and a routine regulatory review, indicating no immediate new risks.
💡 Investor Takeaway
Advanced Enzyme Technologies reported a consolidated net profit after tax of INR 483.06 million for Q2 FY27, up 11.50% from INR 433.26 million in Q2 FY26. Consolidated total income reached INR 2,290.09 million, marking a 7.97% increase from INR 2,120.99 million in Q2 FY26.
⚖️ Strengths & Concerns

✅ Positives

  • Consolidated Net Profit after Tax for Q2 FY27 increased to INR 483.06 million, up from INR 433.26 million in the corresponding prior period.
  • Consolidated Total Income for Q2 FY27 grew to INR 2,290.09 million, compared to INR 2,120.99 million in Q2 FY26.

⚠️ Concerns

  • Total comprehensive income attributable to Non-controlling interests for the half year ended September 30, 2026, was INR 42.60 million, a decline from INR 52.11 million in the prior year.
  • Other comprehensive income (items that will not be reclassified to profit or loss) showed a loss of INR 0.13 million for Q2 FY27.
📅 Company Track Record
In Q4 FY26, Advanced Enzyme Technologies reported a consolidated PAT increase of 69% YoY to INR 453 million on 22% revenue growth. The Board approved FY26 results and proposed a ₹1.35 final dividend, deferring an interim dividend for strategic capital. This filing continues the trend of reporting quarterly financial performance.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Advanced Enzyme Technologies' consolidated net profit for Q2 FY27?
Advanced Enzyme Technologies reported a consolidated Net Profit after Tax of INR 483.06 million for the quarter ended September 30, 2026.
What was Advanced Enzyme Technologies' consolidated total income for the quarter ended September 30, 2026?
The consolidated Total Income for Advanced Enzyme Technologies for the quarter ended September 30, 2026, was INR 2,290.09 million.
What was the consolidated net profit for Advanced Enzyme Technologies for the half year ended September 30, 2026?
For the half year ended September 30, 2026, Advanced Enzyme Technologies reported a consolidated Net Profit after Tax of INR 853.99 million.
What regulatory matter did Advanced Enzyme Technologies' Board analyze?
The Board analyzed requests from promoter group members for reclassification to public category shareholders, pursuant to Regulation 31A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.